Director Dealing

Crism Therapeutics Corporation

03 June 2024

 

3 June 2024

CRISM Therapeutics Corporation

(AIM:CRTX)

Director Dealing

CRISM Therapeutics Corporation ("CRISM" or the "Company") announces that it has been notified that Non-Executive Director, Gerald Beaney has purchased 25,000 ordinary shares of the Company at a price of 9.265 pence per share.

Following this purchase, Mr Beaney holds 25,000 ordinary shares, which represents approximately 0.08% of the Company's total issued share capital of 32,678,312.

Enquiries:

Company	Nomad and Broker	Financial PR
CRISM Therapeutics Corporation	S.P. Angel Corporate Finance LLP	Buchanan
Andrew Webb, CEO Chris McConville, CSO	Richard Morrison Adam Cowl	Mark Court [e-mail] Jamie Hooper [e-mail]
via Buchanan	[phone]	[phone]

Dealings by Persons Discharging Managerial Responsibilities

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Gerald Beaney
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	CRISM Therapeutics Corporation
b)	LEI	213800XFW6MKVCHHPW88
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares with no par value
	Identification code	ISIN: VGG042401262
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)		Director/PDMR Price Volume Gerald Beaney 9.265 25,000
d)	Aggregated information
	- Aggregated volume	25,000
	- Price	£2,316.25
e)	Date of the transaction	3 June 2024
f)	Place of the transaction	Outside a trading venue

 

END